Literature DB >> 12815711

Fractalkine protein localization and gene expression in mouse brain.

G Tarozzo1, S Bortolazzi, C Crochemore, S-C Chen, A S Lira, J S Abrams, M Beltramo.   

Abstract

Few chemokines are expressed constitutively in the brain at detectable levels; amongst them is fractalkine. We analyzed the distribution of fractalkine in the mouse brain with the aim of giving a neuroanatomical support to the study of its physiological function. To this end, we carried out an analysis of fractalkine protein localization and gene expression. An anti-fractalkine antibody was produced and used to perform an immunohistochemical study. The results indicated a high level of fractalkine protein in cortex, hippocampus, basal ganglia, and olfactory bulb. In particular, the presence of abundant immunoreactive neurons was observed in layers II, III, V, and VI of the cortex. In the hippocampus, the CA1 region was the most intensely labeled, but immunoreactive neurons were present also in CA2 and CA3, whereas in the basal ganglia, immunoreactive cells were observed in the caudate putamen. Other brain structures such as the brainstem showed a few scattered immunoreactive cells. The presence of fractalkine immunoreactive fibers was revealed only in the olfactory bulb and in the anterior olfactory nuclei. Gene expression study results, obtained by both semiquantitative PCR and in situ hybridization, matched protein localization with the highest levels of fractalkine transcript detected in the hippocampus, cortex, and striatum. The present study showed that fractalkine protein and mRNA are constitutively expressed at a high level in forebrain structure, but are almost absent in the hindbrain. Furthermore, localization at the cellular body level would suggest a paracrine or cell-to-cell interaction role for fractalkine more than a neurotransmission modulatory function. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815711     DOI: 10.1002/jnr.10645

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  44 in total

1.  In vivo structure/function and expression analysis of the CX3C chemokine fractalkine.

Authors:  Ki-Wook Kim; Alexandra Vallon-Eberhard; Ehud Zigmond; Julia Farache; Elias Shezen; Guy Shakhar; Andreas Ludwig; Sergio A Lira; Steffen Jung
Journal:  Blood       Date:  2011-09-27       Impact factor: 22.113

Review 2.  Regulatory factor X4 variant 3: a transcription factor involved in brain development and disease.

Authors:  Donghui Zhang; Darryl C Zeldin; Perry J Blackshear
Journal:  J Neurosci Res       Date:  2007-12       Impact factor: 4.164

Review 3.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

4.  The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system.

Authors:  Rebecca L Lowery; Marie-Eve Tremblay; Brittany E Hopkins; Ania K Majewska
Journal:  Glia       Date:  2017-08-24       Impact factor: 7.452

5.  CX3CR1 Does Not Universally Mediate Microglia-Neuron Crosstalk during Synaptic Plasticity.

Authors:  Patrick Miller-Rhodes
Journal:  J Neurosci       Date:  2018-05-09       Impact factor: 6.167

6.  Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.

Authors:  Angela M Wynne; Christopher J Henry; Yan Huang; Anthony Cleland; Jonathan P Godbout
Journal:  Brain Behav Immun       Date:  2010-06-04       Impact factor: 7.217

Review 7.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

8.  Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling.

Authors:  Katharine J Liang; Jung Eun Lee; Yunqing D Wang; Wenxin Ma; Aurora M Fontainhas; Robert N Fariss; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

9.  G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator.

Authors:  Donghui Zhang; G Jean Harry; Perry J Blackshear; Darryl C Zeldin
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

10.  Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.

Authors:  Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.